ITGAX and inflammation: In an allergic airway disease model, deletion of IRF4 expression in CD11c+ cells attenuated Th2-type lung inflammation, and IRF4 was found to directly modulate IL-10 and IL-33 production by DCs, promoting Th2 differentiation and inflammation34.